OxyContin maker Purdue Pharma LP won court approval of a multibillion restructuring plan that will turn the drugmaker into a new public benefit company that will use its resources to address the opioid epidemic and compensate people and families harmed by its products.
The restructuring includes roughly $4.5 billion in settlement payments from members of the Sackler family who own the company. Here are details about the settlement plan and how it works.
Read Full Story: https://www.wsj.com/articles/purdue-bankruptcy-plan-settles-opioid-lawsuits-against-founding-family-heres-what-to-know-11630532441
Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.